Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Everything you should know about Harsha Prawin, the rising Indian film music director and music Artist Entertainment
  • How To Heal Cracked Heels? Lifestyle
  • ICED-A-THON 2022, Mega Event in health care For Doctors, Dentists, Dermats, surgeons inaugurated in Goa Press Release
  • The Art Of Dumpling has bagged the Most Prominent Pan Asian Cuisine Restaurant of the Year- 2022, New Delhi By Business Mint Business
  • Viraj Profiles Honors India’s Independence with a Grand Celebration of ‘Viksit Bharat Ki Udaan National
  • Musical Marvel at IPS Academy: ‘Indian Ocean’ Rock Band Enchants Indore with Fusion Spectacle Education
  • Vibhavangal Anukulakara’s 2025 Growth Plan: Insights from Siddharth Maurya Lifestyle
  • Silver Consumer Electricals Closes Up-Round; Valued at Rs. 1,000 Crores Business

Optimus Pharma granted permission for Restricted Use under Emergency Situation from the DCGI for its COVID-19 pill MOLNUPIRAVIR

Posted on December 28, 2021 By

Hyderabad (Telangana) [India], December 28: Hyderabad, Optimus Pharma announced launching of their front line COVID-19 medication Molnupiravir in the Indian market, as they have received permission the restricted emergency use for Covid-19 drug.  Optimus Pharma successfully completed the Phase 3 Clinical Trial on 1218 subjects across 29 geographical study sites all over India. “We want to cover maximum demographic diversity into our trial in order to obtain data across the different geographical regions of the country and conclusive evidence that Molnupiravir is able to bring about viral load reduction over 5 days of treatment duration,” said Chairman and Managing Director of Optimus Pharma, Dr D Srinivasa Reddy. Optimus Pharma has developed the API in the house at its R&D centre in Hyderabad. Optimus Pharma has revealed highly promising results of the drug in its ability to reduce viral load and bring out significant symptomatic improvement in patients’ health.

It is to be noted that in the Clinical Trial, Molnupiravir was administered to the subjects along with Standard of Care (SoC) medication as per the approved protocol by CDSCO. The trial was successful in establishing a clinical significant results of ‘Molnupiravir + SoC’ over ‘SoC’ arm.

  • Rate of hospitalization was less in Molnupiravir+SoC when compared to SoC group.
  • Greater clinical improvement observed in Molnupiravir + SoC arm compared to SOC alone by Day 5 and Day 10.
  • Proportion of subjects with RT-PCR negativity at Day 5 and Day 10 was statistically significant in Molnupiravir + SoC arm.
  • Higher viral load reduction was observed in Molnupiravir+ SoC arm
  • No serious safety concerns observed with Molnupiravir in overall study duration, no mortality was observed in the trial across both the arms

 Molnupiravir is administered as an 800 mg dose by orally consuming four capsules of 200mg twice a day. Upon oral administration, Molnupiravir, being a prodrug, is metabolized into its active form and converted into its triphosphate (TP) form. The TP form of Molnupiravir is incorporated into RNA and inhibits the action of viral RNA-dependent RNA polymerase. This results in the termination of RNA transcription, thereby significantly reducing viral replication.

Optimus Pharma is ready with a commercial quantity of the drug to cater to the unmet medical need of the nation. It is with heartfelt gratitude that we thank the Subject Expert Committee of the CDSCO and the DCGI for their valuable recommendations and guidance for the Clinical Trial, thereby making this project a huge success, said Dr D. Srinivas Reddy (MD Optimus) in his statement to the press. Optimus Pharma is committed to consistently integrating quality, affordability and reliability into their products and ensuring timely access to life-saving medication to whomsoever is in need.

Business Tags:Business

Post navigation

Previous Post: Candid chat with Mrs India Earth Poonam Chaubey
Next Post: Babubhai Sweets From Surat Sets World Record For Biggest Ghari 15 Kg and Smallest Ghari 15 Gm

Related Posts

  • PAFI Appoints T.S. Vishwanath as Director General Business
  • Upcopy.ai: British-headquartered Edtech startup has become students’ go-to writing platform to fix language errors, improve grades and save time   Business
  • Kavita Kaushal won the title of “Marvelous Mrs. India Talented 2024 Business
  • Entice Coin is gearing up for yet another major event in the crypto industry Business
  • Neetu Yoshi Limited IPO Opens on June 27, 2025 Business
  • aerpace Industries unveils aerWing, marks a huge leap forward in sustainable transportation Business

Recent Posts

  • Nitrro Bespoke Fitness Powai’s 6th Anniversary Was a Stellar Celebration of Strength & Style Spearheaded by Prabodh V. Davkhare
  • Unity for Growth: Leaders Unite for a Developed India Vision
  • Sarvajanik University Represents India at Prestigious 19th World Sanskrit Conference in Nepal
  • Jacqueline Fernandez, Sanya Malhotra and Jackie Shroff back Shriyam Bhagnani’s Sumo Didi
  • Mumbai’s Komal Vaidya Takes Centre Stage with Silver Category Win at National Pageant

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Rasayana Ayurveda: The Path to Transformation – Dr. Bommu Venkateshwara Reddy’s Story Health
  • Say No To Drugs – Event organised by Youth Nation founded by entrepreneur Veekas Champalal Doshi Business
  • Nawah’s Continued Commitment to Quality Fuels Customer Trust Business
  • The Changing Room By Geetika Saigal Promises To Help Readers Survive & Succeed In Uncertain Times. Lifestyle
  • The Golden Boy of Kolkata brings immense pride to the nation again Business
  • EVIFY sets stone for expansion through its next fund raise Business
  • Role of Mutual Fund Distributors in Promoting Financial Literacy Finance
  • Multi-talented Anu Chauhan Triumphs as Marvelous Mrs. India Social Media Queen 2024 Entertainment

Copyright © 2025 Daily News India.

Powered by PressBook News WordPress theme